Journal of Molecular Medicine 2021

2 papers

Top Research Directions

The 3 research directions with Journal of Molecular Medicine 2021 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1The Pretreatment to Clinical Translation Gap for Rescue Therapies150.0%
2The Secondary Injury Cascade in Central Nervous System Trauma150.0%
3Validating Causal Mechanisms via Pharmacological Pathway Inhibition150.0%

Download all directions as CSV

Institutions

Institutions credited by Journal of Molecular Medicine 2021 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1Christian-Albrechts-Universität zu Kiel 1100.0%

Download all institutions as CSV

About this data

Papers. Journal of Molecular Medicine 2021 lists 2 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 2 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Molecular Medicine 2021”, https://lacuna.tiptreesystems.com/venue/journal-of-molecular-medicine/2021.

Impactful Papers

Papers from Journal of Molecular Medicine 2021 that shaped research clusters.

Influential

Papers

Title
Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases
Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K/Akt and Nrf2/ARE pathways